Yury V Popov

Years Active: 2024-2024
Publications (10 Years): 3

This page only lists publications with an associated author ORCID identifier.

Publications

Zhenwei Peng, Guangyan Wei, Pinzhu Huang, Heansika Matta, Wen Gao, Ping An, Shuangshuang Zhao, Yi Lin, Li Tan, Kahini Vaid, Disha Skelton-Badlani, Imad Nasser, Grant Budas, David Lopez, Li Li, David Breckenridge, Rob Myers, John McHutchison, Ming Kuang, Yury V Popov
ASK1/ p38 axis inhibition blocks the release of mitochondrial "danger signals" from hepatocytes and suppresses progression to cirrhosis and liver cancer. Hepatology (Baltimore, Md.) 80 (2) (2024)
Zhenwei Peng, Guangyan Wei, Pinzhu Huang, Heansika Matta, Wen Gao, Ping An, Shuangshuang Zhao, Yi Lin, Li Tan, Kahini Vaid, Disha Skelton-Badlani, Imad Nasser, Grant Budas, David Lopez, Li Li, David Breckenridge, Rob Myers, John McHutchison, Ming Kuang, Yury V Popov
ASK1/ p38 axis inhibition blocks the release of mitochondrial "danger signals" from hepatocytes and suppresses progression to cirrhosis and liver cancer. Hepatology (Baltimore, Md.) 80 (2) (2024)
Zhenwei Peng, Guangyan Wei, Pinzhu Huang, Heansika Matta, Wen Gao, Ping An, Shuangshuang Zhao, Yi Lin, Li Tan, Kahini Vaid, Disha Skelton-Badlani, Imad Nasser, Grant Budas, David Lopez, Li Li, David Breckenridge, Rob Myers, John McHutchison, Ming Kuang, Yury V Popov
ASK1/ p38 axis inhibition blocks the release of mitochondrial "danger signals" from hepatocytes and suppresses progression to cirrhosis and liver cancer. Hepatology (Baltimore, Md.) (2024)

Yury V Popov.css-eqlu8i{font-size:small;padding-left:4px;}